FDA Approves Subcutaneous Risankizumab for Crohn’s Disease
FDA Approves Subcutaneous Risankizumab for Crohn's Disease Gastroenterology & Endoscopy News
Finance, IT & News
FDA Approves Subcutaneous Risankizumab for Crohn's Disease Gastroenterology & Endoscopy News
Fitch Ratings upgrades Georgia’s sovereign rating outlook from stable to positive, affirms BB rating BM.GE
S&P Cuts Meta Credit Rating Outlook to 'Negative' on AI Investment Burden, Warns on Cash Flow BigGo Finance
S&P Global cuts Meta’s outlook to ‘negative’ over high AI spending TechCentral.ie
Zambia gains lenders’ trust, as Moody’s upgrades country’s credit rating News Diggers!